BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26383592)

  • 1. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal phototoxic dose (MPD) measurements for topical photochemotherapy using a semiautomated MPD tester.
    Al-Ismail D; Edwards C; Al-Ofi O; Anstey AV
    Br J Dermatol; 2013 Sep; 169(3):687-9. PubMed ID: 23607709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polychromatic action spectrum for photosensitivity to orally administered 8-methoxypsoralen in humans.
    Bech-Thomsen N; Wulf HC
    Clin Exp Dermatol; 1994 Jan; 19(1):12-5. PubMed ID: 8313631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
    Azurdia RM; Dean MP; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):186-8. PubMed ID: 11019945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prediction of the minimal phototoxic dose in PUVA therapy.
    Sakuntabhai A; Matthews JN; Farr PM
    Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the minimal phototoxic dose and colorimetry in psoralen plus ultraviolet A radiation therapy.
    Kraemer CK; Menegon DB; Cestari TF
    Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):242-8. PubMed ID: 16149936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
    Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
    Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of PUVA bath phototoxicity.
    Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
    Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
    Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.